株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

凝固検査の世界市場:2017〜2021年

Global Coagulation Testing Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 317277
出版日 ページ情報 英文 81 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.28円で換算しております。
Back to Top
凝固検査の世界市場:2017〜2021年 Global Coagulation Testing Market 2017-2021
出版日: 2017年01月27日 ページ情報: 英文 81 Pages
概要

凝固検査は、血液の凝固能力を測定するのに役立ちます。凝固とは、血液が液体からジェル状に変換するプロセスです。世界の凝固検査市場は、2017年から2021年にかけて6.43%の年間成長率(CAGR)で推移することが見込まれています。

当レポートでは、世界の凝固検査市場について調査分析し、市場規模、応用、技術、製品、エンドユーザー、地域別の詳細な市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 調査範囲

  • 市場概要
  • 主な製品

第3章 調査手法

  • 調査手法
  • 経済指標

第4章 イントロダクション

第5章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 市場区分:応用別

  • 市場概要
  • プロトロンビン時間(PT)
  • 活性化部分トロンボプラスチン時間(APTT)
  • トロンボテスト(TT)
  • 活性化凝固時間(ACT)

第7章 市場区分:技術別

  • 電気化学
  • 光学

第8章 市場区分:製品別

  • 市場概要
  • 消耗品
  • 器具・機器
  • 市場規模と予測

第9章 市場区分:エンドユーザー別

  • 市場概要
  • 病院・個人診療所
  • 在宅ケア

第10章 地域区分

  • 南北アメリカの凝固検査市場
  • 欧州・中東・アフリカ地域の凝固検査市場
  • アジア太平洋地域の凝固検査市場

第11章 市場の促進要因

  • 血液・凝固系疾病の増加に伴う凝固検査機器の需要の増加
  • 発展国におけるポイントオブケア検査(POCT)の浸透率の上昇
  • センサー技術の発展による簡便な機器の登場

第12章 促進要因の影響

第13章 市場の課題

  • 高額な全自動血液凝固機器
  • 電子カルテの接続性の低さ
  • 規制上の課題によって機器の安定供給が阻害されている現状

第14章 促進要因と課題の影響

第15章 市場の動向

  • オンラインマーケティングサービスの拡大
  • 使い捨て凝固検査製品の人気の上昇
  • 手術前後に凝固検査を行う医師の増加

第16章 ベンダーの情勢

  • 競合環境
  • 競合環境の分析

第17章 主要ベンダーの分析

  • Roche Diagnostics
  • Alere
  • Abbott Laboratories
  • Siemens Healthcare
  • その他のベンダー

第18章 付録

第19章 Technavioについて

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR11734

About Coagulation Testing

Coagulation testing helps measure the ability of blood to form a clot. Clotting occurs when blood converts from liquid to gel form. Coagulation tests are performed to analyze clotting disorders, such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving the quality of life of patients.

Technavio's analysts forecast the global coagulation testing market to grow at a CAGR of 6.43% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global coagulation testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the various segments which includes products, application, and technology.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Coagulation Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Roche Diagnostics
  • Alere
  • Abbott Laboratories
  • Siemens Healthcare

Other Prominent Vendors

  • Accriva Diagnostics
  • CoaguSense
  • Diagon
  • Helena Laboratories
  • HemoSonics
  • iLine Microsystems
  • Medtronic
  • Micropoint Bioscience
  • Sysmex

Market driver

  • Increased penetration of POCT devices in developed countries
  • For a full, detailed list, view our report

Market challenge

  • High cost of fully-automated hemostasis equipment
  • For a full, detailed list, view our report

Market trend

  • Increase in online marketing services
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our procurement specialist's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • Market overview
  • PT
  • aPTT
  • TT
  • ACT

PART 07: Market segmentation by technology

  • Electrochemical
  • Optical

PART 08: Market segmentation by product

  • Market overview
  • Consumables
  • Market size and forecast
  • Instruments

PART 09: Market segmentation by end-user

  • Market overview
  • Hospitals and private clinics
  • Home care

PART 10: Geographical segmentation

  • Global coagulation testing market in the Americas
  • Global coagulation testing market in EMEA
  • Global coagulation testing market in APAC

PART 11: Market drivers

  • Increasing prevalence of coagulation disorders driving the demand for coagulation testing devices
  • Increased penetration of POCT devices in developed countries
  • Technological advancements in sensors technology leads to faster and easy-to-use devices

PART 12: Impact of drivers

PART 13: Market challenges

  • High cost of fully-automated hemostasis equipment
  • Low data management and EHR connectivity
  • Regulatory challenges restrict the availability of the devices in the market

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Increase in online marketing services
  • Growing popularity of disposable coagulation testing products
  • Increasing physician preference for coagulation tests in pre-and post-surgical proceedings

PART 16: Vendor landscape

  • Competitive scenario
  • Competitive landscape analysis

PART 17: Key vendor analysis

  • Roche Diagnostics
  • Alere
  • Abbott Laboratories
  • Siemens Healthcare
  • Other prominent vendors

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global coagulation testing market 2016-2021 ($ billions)
  • Exhibit 03: Global coagulation testing market: Opportunity analysis
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global coagulation testing market by application 2016 and 2021 (%)
  • Exhibit 06: Global POC coagulation market by application 2016 and 2021 (%)
  • Exhibit 07: Global coagulation testing market by technology
  • Exhibit 08: Global coagulation electrochemical sensors testing market ($ billions)
  • Exhibit 09: Global coagulation optical biosensors testing market ($ billions)
  • Exhibit 10: Global coagulation testing consumables market ($ billions)
  • Exhibit 11: Global coagulation testing consumables market strategy analysis
  • Exhibit 12: Global coagulation instruments market 2015-2020 ($ billions)
  • Exhibit 13: Global coagulation testing instrument market strategy analysis
  • Exhibit 14: Global coagulation testing market 2016-2021 (%)
  • Exhibit 15: Global coagulation market analysis by hospitals and private clinics
  • Exhibit 01: Global coagulation market analysis by home care
  • Exhibit 02: Global coagulation testing market share by geography 2016-2021 (%)
  • Exhibit 03: Global coagulation testing market in Americas 2016-2021 ($ billion)
  • Exhibit 04: Global coagulation testing market in EMEA 2016-2021 ($ billions)
  • Exhibit 05: Global coagulation testing market in APAC 2016-2021 ($ billions)
  • Exhibit 06: Coagulation disorder market matrix
  • Exhibit 07: Impact of drivers
  • Exhibit 08: Cost analysis of coagulation devices
  • Exhibit 09: Impact of drivers and challenges
  • Exhibit 10: Competitive structure analysis of global coagulation testing market 2016
  • Exhibit 11: Competitive landscape analysis of global coagulation testing market (2016)
  • Exhibit 12: Roche Diagnostics: Key highlights
  • Exhibit 13: Roche Diagnostics: Strength assessment
  • Exhibit 14: Roche Diagnostics: Strategy assessment
  • Exhibit 15: Roche diagnostics: Opportunity assessment
  • Exhibit 16: Alere: Key highlights
  • Exhibit 17: Alere: Strength assessment
  • Exhibit 18: Alere: Strategy assessment
  • Exhibit 19: Alere: Opportunity assessment
  • Exhibit 20: Abbott Laboratories: Key highlights
  • Exhibit 21: Abbott Laboratories: Strength assessment
  • Exhibit 22: Abbott Laboratories: Strategy assessment
  • Exhibit 23: Abbott Laboratories: Opportunity assessment
  • Exhibit 24: Siemens Healthcare: Key highlights
  • Exhibit 25: Siemens Healthcare: Strength assessment
  • Exhibit 26: Siemens Healthcare: Strategy assessment
  • Exhibit 27: Siemens Healthcare: Opportunity assessment
  • Exhibit 28: Other prominent vendors
Back to Top